Skip to main content
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Peter R. Brinck
Sign up to set email alerts
5
Publications
60
Citation Statements Received
169
Citation Statements Given
How they've been cited
102
5
54
1
How they cite others
152
0
169
0
Affiliations
Novo Nordisk (Denmark)
,
Leo Pharma (Denmark)
Publications
Order By: Most citations
Generalized Cellular Hypertrophy is Induced by a Dual-Acting PPAR Agonist in Rat Urinary Bladder Urothelium In Vivo
Oleksiewicz
1
,
Thorup
2
,
Nielsen
3
et al.
2005
Toxicol Pathol
Abstract
Show
45
3
37
1
Get access via publisher
Add to collection
Cite
Toxicity of Vitamin D Analogues in Rats Fed Diets with Standard or Low Calcium Contents
Brinck
1
,
Binderup
2
1993
Pharmacology & Toxicology
Abstract
Show
24
2
8
0
Get access via publisher
Add to collection
Cite
The Dog as a Second Species for Toxicology Testing Provides Value to Drug Development
Bower
1
,
Achanzar
2
,
Boulifard
3
et al.
2022
Int J Toxicol
Abstract
Show
11
0
4
0
Get access via publisher
Add to collection
Cite
Evaluation of Cell Proliferation in Rat Mammary Glands Is Not Predictive of the Carcinogenic Potential of Insulin In Vivo
Jensen
1
,
Brinck
2
,
Nowak
3
et al.
2020
Int J Toxicol
Abstract
Show
4
0
3
0
Get access via publisher
Add to collection
Cite
Endeavours made by trade associations, pharmaceutical companies and regulators in the replacement, reduction and refinement of animal experimentation in safety testing of pharmaceuticals
Harrell
1
,
Reid
2
,
Vahle
3
et al.
2024
Regulatory Toxicology and Pharmacology
18
0
2
0
Get access via publisher
Add to collection
Cite
1